AstraZeneca PLC is 208.1x more valuable than MoonLake Immunotherapeutics by market capitalization ($286.27 B vs $1.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MLTX | AZN |
|---|---|---|
| Market cap | $1.38 B | $286.27 B |
| US-listed rank | #2416 | #49 |
| Net income (latest FY) | -$227.32M | - |
| SEC filings | 296 | 1,004 |
AstraZeneca PLC is 208.1x more valuable than MoonLake Immunotherapeutics by market capitalization ($286.27 B vs $1.38 B).
Full pages: MoonLake Immunotherapeutics and AstraZeneca PLC, or browse the full rankings.